Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEM81 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PHYKPL | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZDHHC20 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ZCCHC9 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | A4GALT | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | KCNAB3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | NFKBID | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | IFNL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | LMO2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | RFXAP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |